Screening for neurocognitive impairment in pediatric cancer long-term survivors. - Wikidata - awgldk - TriplyDB

Screening for neurocognitive impairment in pediatric cancer long-term survivors.

Screening for neurocognitive impairment in pediatric cancer long-term survivors.

http://www.wikidata.org/entity/Q50122627

about

Developing interventions for cancer-related cognitive dysfunction in childhood cancer survivors Effects of early chemotherapeutic treatment on learning in adolescent mice: implications for cognitive impairment and remediation in childhood cancer survivors Development of a parent-report cognitive function item bank using item response theory and exploration of its clinical utility in computerized adaptive testing.Ages and Stages Questionnaires-3 developmental screening of infants and young children with cancer.Emotional distress among adult survivors of childhood cancer.A proposed framework to standardize the neurocognitive assessment of patients with pediatric systemic lupus erythematosus Neurocognitive deficits and neuroimaging abnormalities are prevalent in children with lupus: clinical and research experiences at a US pediatric institution Pretreatment neuropsychological deficits in children with brain tumors Folate pathway polymorphisms predict deficits in attention and processing speed after childhood leukemia therapy.Predictors of independent living status in adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study.Symptoms of attention-deficit/hyperactivity disorder in long-term survivors of childhood leukemia Utility of the N-back task in survivors of childhood acute lymphoblastic leukemia.Child-related characteristics predicting subsequent health-related quality of life in 8- to 14-year-old children with and without cerebellar tumors: a prospective longitudinal study Increase in oxidative stress as measured by cerebrospinal fluid lipid peroxidation during treatment for childhood acute lymphoblastic leukemia.Mathematics intervention for prevention of neurocognitive deficits in childhood leukemia Oxidative Stress, Motor Abilities, and Behavioral Adjustment in Children Treated for Acute Lymphoblastic Leukemia Screening for cognitive deficits in 8 to 14-year old children with cerebellar tumors using self-report measures of executive and behavioral functioning and health-related quality of life.Neurocognitive Predictors of Academic Outcomes Among Childhood Leukemia Survivors The peabody picture vocabulary test as a pre-screening tool for global cognitive functioning in childhood brain tumor survivors.Genetic mediators of neurocognitive outcomes in survivors of childhood acute lymphoblastic leukemia Psychological status in childhood cancer survivors: a report from the Childhood Cancer Survivor Study.Neurocognitive outcomes decades after treatment for childhood acute lymphoblastic leukemia: a report from the St Jude lifetime cohort study.Chemotherapy-related changes in central nervous system phospholipids and neurocognitive function in childhood acute lymphoblastic leukemia.Standard of Care for Neuropsychological Monitoring in Pediatric Neuro-Oncology: Lessons From the Children's Oncology Group (COG).Dexamethasone exposure and memory function in adult survivors of childhood acute lymphoblastic leukemia: A report from the SJLIFE cohort.Disruption of learning processes by chemotherapeutic agents in childhood survivors of acute lymphoblastic leukemia and preclinical models Mathematics development and difficulties: the role of visual-spatial perception and other cognitive skills.Brief neurocognitive screening in youth with brain tumours: A preliminary investigation of the Lebby-Asbell Neurocognitive Screening Examination (LANSE).Monitoring and Assessment of Neuropsychological Outcomes as a Standard of Care in Pediatric Oncology.Implementing guidelines: Proposed definitions of neuropsychology services in pediatric oncology.Parent-reported cognitive function is associated with leukoencephalopathy in children with brain tumors.Brain volume and cognitive function in adult survivors of childhood acute lymphoblastic leukemia.The PETALE study: Late adverse effects and biomarkers in childhood acute lymphoblastic leukemia survivors.Feasibility of neurobehavioral screening following diagnosis of pediatric cancer.Parental reports of behavioural outcome among paediatric leukaemia survivors in Malaysia: a single institution experience.The contribution of neurocognitive functioning to quality of life after childhood acute lymphoblastic leukemia.Parental stress predicts functional outcome in pediatric cancer survivors.Systematic Review: A Prevention-Based Model of Neuropsychological Assessment for Children With Medical Illness.

P2860

Q26825655-C6565ECC-3117-4DC0-AEA5-AA643AB515ED Q30540341-ED886D98-5B05-4F1E-BAC9-F3C74638763A Q33453444-04A5D945-1279-400D-B0FA-8A7A57C3A7A6 Q33632338-F683B109-AF53-476E-BF12-8F33F8A5DB07 Q33902955-9C0C007A-8EDE-4BA7-AB1C-62A1896CFCE5 Q34114987-9C55AF38-5443-4B12-9794-DB2C90E40123 Q34307491-E16DD6F4-3033-4FFA-8D5F-178EB90F315D Q34977364-B8FAC064-A3FD-4F37-95C8-F0F3CB4B7ACD Q35098712-092D3CB3-2B55-48B4-A651-7278182603BE Q35115644-4E8889C9-4EDA-474C-B443-51E9AEFF731D Q35119007-02DCA58D-F4EE-41E7-9001-15CA45AEAE78 Q35166450-F98B89CB-CFBE-455F-848B-68B4DEE3623A Q35206193-E9314AF9-75AD-4CFB-ABC6-D967C55B26CE Q35580998-CD78ED8A-CC15-42EE-BEA0-991461DFA22A Q35635557-D5A71787-EB53-4F89-8020-EE596EFA4E7B Q35999979-942DAEE2-48C3-4532-B8A1-03D8C42E8A08 Q36250749-4AC08FE2-518D-4FF6-853E-870C205ACB03 Q36445713-48D4DCE3-01CD-4E70-B525-F411C6C8FAE9 Q36926438-94CBF07D-1B97-4377-8BF2-271D49ADCE20 Q37065825-D819659C-5958-48D2-B209-571ED4EEBCA5 Q37181691-1F165519-6556-4DE4-8E21-27A0F77E0113 Q37348625-6F38815F-BEF2-4C45-8F1D-7D3B8255FA05 Q37352921-ED7449A9-0CBD-402D-906A-1F1873530ABD Q37574355-894375E6-8ADE-4E26-A3FB-99588ED42A5F Q37592251-93D1CFA6-9D93-4FC2-8958-96110E24C64E Q37879488-50300F5C-1B49-47C5-A41A-3A8FCD4CBB1D Q38186676-62A8DC58-CD4B-408E-9FA8-B4BA606777BA Q38525628-19F67591-49CD-4649-AD85-384A80D2CDA3 Q38678301-A889DDD5-2874-4C75-866F-903D28D7034B Q38766052-2565F2AD-32FD-41DF-A35D-9A56A1B50C02 Q38817735-12E0E373-59A2-47ED-90CA-1DB5B45A3CA5 Q40033058-77E6D546-BC1D-452C-96A2-D8ACE049E190 Q40441874-8F06293E-9BCD-4A31-B89D-4ED386C397E7 Q44661638-C928DCD4-79CE-4CD6-A42B-E6047AA9B5E0 Q47843489-1ED2969D-F0BE-4168-B16C-10596E95BC6C Q48086635-857FA6BC-4444-446B-AA96-F88A35CFE759 Q50687582-1648CD85-CFB7-41AE-AD16-742243C2AD05 Q50755704-28411EB4-09BC-4222-A563-3F558E8D92BB

P2860

Screening for neurocognitive impairment in pediatric cancer long-term survivors.

http://www.wikidata.org/entity/Q50122627

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh

2008年學術文章

@zh-hant

name

Screening for neurocognitive impairment in pediatric cancer long-term survivors.

@en

Screening for neurocognitive impairment in pediatric cancer long-term survivors.

@nl

type

label

Screening for neurocognitive impairment in pediatric cancer long-term survivors.

@en

Screening for neurocognitive impairment in pediatric cancer long-term survivors.

@nl

prefLabel

Screening for neurocognitive impairment in pediatric cancer long-term survivors.

@en

Screening for neurocognitive impairment in pediatric cancer long-term survivors.

@nl

P1433

Q50122627-2C6B6161-2315-43B8-93A2-0BCE1C2E504C

P1476

Q50122627-ED6DD938-1846-49A3-B84B-5D1D8A9848BE

P2093

Q50122627-1670CEEB-4DBE-4093-B0AC-F69E87C606C3

Q50122627-88C8876E-AEA8-4E1F-AF2E-067D971D09BC

Q50122627-8A8CEB26-6FE9-4B32-A3DE-0414E3AA4DD1

Q50122627-B1A230FB-9EF2-41CC-891F-C0B2ABECE705

Q50122627-C7C93EE1-256F-4296-BFB9-7826CFF63FC3

Q50122627-DB2C3155-BE49-41D6-98B6-387845927807

Q50122627-E2EB49A8-1061-4B93-9802-43856F75CDF0

P304

Q50122627-99F08C59-0841-4D12-9D4F-03E73B830AC6

P31

Q50122627-160AE3A7-1514-4C21-8740-AC6886AEDBDE

P356

Q50122627-FD976ADB-FA05-4567-9FEB-9CF47C2D5F03

P407

Q50122627-19607C93-DD0B-43F6-880B-291CAB0AD27A

P433

Q50122627-B4680064-3A39-4567-8064-229E563C32CA

P478

Q50122627-CBD79848-1882-4C35-9E7E-705F5F8CB51D

P577

Q50122627-4E258309-7403-40D5-8BA3-34494AD440B3

P698

Q50122627-408F3EEC-B2B0-4002-A8F9-84B80E5A54A2

P356

JCO.2008.16.8864

P1433

Journal of Clinical Oncology

P1476

Screening for neurocognitive impairment in pediatric cancer long-term survivors.

@en

P2093

Brian Potter

http://www.w3.org/2001/XMLSchema#string

Kala Kamdar

http://www.w3.org/2001/XMLSchema#string

Kevin R Krull

http://www.w3.org/2001/XMLSchema#string

M Fatih Okcu

http://www.w3.org/2001/XMLSchema#string

Neelam Jain

http://www.w3.org/2001/XMLSchema#string

Pim Brouwers

http://www.w3.org/2001/XMLSchema#string

ZoAnn Dreyer

http://www.w3.org/2001/XMLSchema#string

P304

4138-4143

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2008.16.8864

http://www.w3.org/2001/XMLSchema#string

P407

P433

25

http://www.w3.org/2001/XMLSchema#string

P478

26

http://www.w3.org/2001/XMLSchema#string

P577

2008-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18757327

http://www.w3.org/2001/XMLSchema#string